Compare PLOW & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLOW | TBPH |
|---|---|---|
| Founded | 1948 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 908.9M |
| IPO Year | 2010 | 2013 |
| Metric | PLOW | TBPH |
|---|---|---|
| Price | $41.61 | $16.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $51.50 | $18.40 |
| AVG Volume (30 Days) | 333.2K | ★ 503.9K |
| Earning Date | 05-04-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.67% | N/A |
| EPS Growth | N/A | ★ 279.13 |
| EPS | ★ 1.33 | N/A |
| Revenue | ★ $656,053,000.00 | $15,386,000.00 |
| Revenue This Year | $13.71 | $8.46 |
| Revenue Next Year | $5.36 | N/A |
| P/E Ratio | $31.96 | ★ N/A |
| Revenue Growth | ★ 15.40 | N/A |
| 52 Week Low | $28.52 | $12.79 |
| 52 Week High | $55.00 | $21.03 |
| Indicator | PLOW | TBPH |
|---|---|---|
| Relative Strength Index (RSI) | 38.06 | 52.58 |
| Support Level | $37.66 | $16.80 |
| Resistance Level | $46.91 | $16.92 |
| Average True Range (ATR) | 1.90 | 0.04 |
| MACD | -0.18 | -0.00 |
| Stochastic Oscillator | 37.71 | 54.17 |
Douglas Dynamics Inc is a manufacturer and upfitter of commercial vehicle attachments and equipment. The Company's portfolio includes snow and ice management attachments sold under the BLIZZARD, FISHER, HENDERSON, SNOWEX, and WESTERN brands, turf care equipment under the TURFEX brand, and industrial maintenance equipment under the SWEEPEX brand. The Company's portfolio also includes the upfit of attachments and storage solutions under the HENDERSON brand, and the DEJANA brand and its related sub-brands. The Company also leases fifteen manufacturing upfit and service facilities located in Iowa, Maryland, Missouri, New Jersey, New York, Ohio, Pennsylvania, and Rhode Island. The Company conducts business in two segments: Work Truck Attachments and Work Truck Solutions.
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.